ASRT
Price
$0.65
Change
-$0.02 (-2.99%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
91.13M
56 days until earnings call
TXMD
Price
$1.12
Change
-$0.01 (-0.88%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
24.32M
74 days until earnings call
Interact to see
Advertisement

ASRT vs TXMD

Header iconASRT vs TXMD Comparison
Open Charts ASRT vs TXMDBanner chart's image
Assertio Holdings
Price$0.65
Change-$0.02 (-2.99%)
Volume$205
Capitalization91.13M
TherapeuticsMD
Price$1.12
Change-$0.01 (-0.88%)
Volume$2.16K
Capitalization24.32M
ASRT vs TXMD Comparison Chart
Loading...
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASRT vs. TXMD commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASRT is a Buy and TXMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ASRT: $0.65 vs. TXMD: $1.12)
Brand notoriety: ASRT and TXMD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ASRT: 56% vs. TXMD: 82%
Market capitalization -- ASRT: $91.13M vs. TXMD: $24.32M
ASRT [@Pharmaceuticals: Other] is valued at $91.13M. TXMD’s [@Pharmaceuticals: Other] market capitalization is $24.32M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASRT’s FA Score shows that 0 FA rating(s) are green whileTXMD’s FA Score has 0 green FA rating(s).

  • ASRT’s FA Score: 0 green, 5 red.
  • TXMD’s FA Score: 0 green, 5 red.
According to our system of comparison, TXMD is a better buy in the long-term than ASRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASRT’s TA Score shows that 5 TA indicator(s) are bullish while TXMD’s TA Score has 5 bullish TA indicator(s).

  • ASRT’s TA Score: 5 bullish, 5 bearish.
  • TXMD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TXMD is a better buy in the short-term than ASRT.

Price Growth

ASRT (@Pharmaceuticals: Other) experienced а -3.93% price change this week, while TXMD (@Pharmaceuticals: Other) price change was -24.32% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.45%. For the same industry, the average monthly price growth was +14.82%, and the average quarterly price growth was +63.61%.

Reported Earning Dates

ASRT is expected to report earnings on Jul 31, 2025.

TXMD is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASRT($91.1M) has a higher market cap than TXMD($24.3M). ASRT has higher P/E ratio than TXMD: ASRT (1.21) vs TXMD (0.47). TXMD YTD gains are higher at: 31.395 vs. ASRT (-23.476). TXMD has higher annual earnings (EBITDA): 52.6M vs. ASRT (-222.9M). ASRT has more cash in the bank: 73.4M vs. TXMD (10.2M). TXMD has less debt than ASRT: TXMD (8.2M) vs ASRT (39.7M). ASRT has higher revenues than TXMD: ASRT (152M) vs TXMD (69.4M).
ASRTTXMDASRT / TXMD
Capitalization91.1M24.3M375%
EBITDA-222.9M52.6M-424%
Gain YTD-23.47631.395-75%
P/E Ratio1.210.47255%
Revenue152M69.4M219%
Total Cash73.4M10.2M720%
Total Debt39.7M8.2M484%
FUNDAMENTALS RATINGS
ASRT vs TXMD: Fundamental Ratings
ASRT
TXMD
OUTLOOK RATING
1..100
6356
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9291
PRICE GROWTH RATING
1..100
6464
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
4450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TXMD's Valuation (50) in the Pharmaceuticals Generic industry is in the same range as ASRT (80) in the Pharmaceuticals Major industry. This means that TXMD’s stock grew similarly to ASRT’s over the last 12 months.

TXMD's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as ASRT (100) in the Pharmaceuticals Major industry. This means that TXMD’s stock grew similarly to ASRT’s over the last 12 months.

TXMD's SMR Rating (91) in the Pharmaceuticals Generic industry is in the same range as ASRT (92) in the Pharmaceuticals Major industry. This means that TXMD’s stock grew similarly to ASRT’s over the last 12 months.

TXMD's Price Growth Rating (64) in the Pharmaceuticals Generic industry is in the same range as ASRT (64) in the Pharmaceuticals Major industry. This means that TXMD’s stock grew similarly to ASRT’s over the last 12 months.

ASRT's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as TXMD (100) in the Pharmaceuticals Generic industry. This means that ASRT’s stock grew similarly to TXMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASRTTXMD
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 24 days ago
69%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XFOR4.040.08
+2.02%
X4 Pharmaceuticals Inc
AFCG5.410.09
+1.69%
Advanced Flower Capital Inc
BBD2.93-0.03
-0.90%
Banco Bradesco SA
RYTM64.39-1.27
-1.94%
Rhythm Pharmaceuticals
GDEN27.18-1.20
-4.23%
Golden Entertainment

ASRT and

Correlation & Price change

A.I.dvisor tells us that ASRT and OGI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASRT and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASRT
1D Price
Change %
ASRT100%
-0.52%
OGI - ASRT
28%
Poorly correlated
+0.75%
SNOA - ASRT
27%
Poorly correlated
-4.23%
AQST - ASRT
26%
Poorly correlated
+7.23%
TLRY - ASRT
26%
Poorly correlated
+2.17%
INDV - ASRT
26%
Poorly correlated
+7.85%
More

TXMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TXMD has been loosely correlated with LIEN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TXMD jumps, then LIEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TXMD
1D Price
Change %
TXMD100%
+4.63%
LIEN - TXMD
36%
Loosely correlated
-2.45%
DRRX - TXMD
32%
Poorly correlated
+1.05%
TLRY - TXMD
29%
Poorly correlated
+2.17%
ASRT - TXMD
27%
Poorly correlated
-0.52%
SCYX - TXMD
25%
Poorly correlated
+6.25%
More